Clinical Trial

Biomarker Signature-Supported Antibiotic Treatment Decisions in ICU

Name: Biomarker Signature-Supported Antibiotic Treatment Decisions in ICU — clinical trial record (NCT07481773)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: BAST-ICU

Recruiting

View on ClinicalTrials.gov →

Summary

The goal of this randomized clinical trial is to determine whether a biomarker-signature (BV) supported antibiotic treatment decision matrix can have a beneficial impact on antibiotic use and patient outcomes in an ICU population.

Trial Details

NCT Number	NCT07481773
Lead Sponsor	McGill University Health Centre/Research Institute of the McGill University Health Centre Collaborators: Canadian Institutes of Health Research (CIHR)
Conditions	Intensive Care Unit (ICU) Admission
Enrollment	1,200 participants
Start Date	2025-05-13
Primary Completion	2028-05 (estimated)
Study Completion	2028-08 (estimated)
Updated on ClinicalTrials.gov	2026-03-19